Skip to content

To Investigate Effects of Amway Bundle Combination of Products on Osteoarthritis & Sarcopenia

A Randomized, Double-blind Controlled Trial to Investigate Effects of Amway Bundle Combination of Products on Osteoarthritis & Sarcopenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05872360
Enrollment
240
Registered
2023-05-24
Start date
2023-05-27
Completion date
2024-02-28
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Sarcopenia

Keywords

Amway, Nutrilite Lifestyle, EMS (Electric Muscle Stimulation)

Brief summary

The goal of this interventional study is to evaluate the effects of bundle combination of Amway All-plant protein booster with Nutrilite Lifestyle guideline and/or EMS (Electric Muscle Stimulation) device on Osteoarthritis & Sarcopenia in the middle-aged and elderly (50-70 years old) people. 240 eligible participants will be randomly assigned to 4 equal size study groups (ideally 52 for each group will complete the study) in the two study centers in Shanghai, three site visits will be made during the 6 months of study after screening test. All clinical data will be measured /captured on paper CRF(Case Report Form) and then recorded into CTMS(Clinical Trial Data Management System) for analysis and reporting. It's essential that participants should practice with the assigned guideline and device besides taking the products per day. Researchers will compare the four groups to see if there is significant improvement of Amway study products with bundle combination of Nutrilite Lifestyle guideline and/or EMS on Osteoarthritis & Sarcopenia in the participants.

Interventions

DIETARY_SUPPLEMENTBundle Group 1 with Nutrilite Lifestyle

All-plant protein booster: 2 spoons (15g), twice per day. Calcium & Magnesium:3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day. Practice according to Nutrilite Lifestyle Guideline per day.

DIETARY_SUPPLEMENTBundle Group 2 without Nutrilite Lifestyle

All-plant protein booster: 2 spoons (15g), twice per day. Calcium & Magnesium:3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day.

DIETARY_SUPPLEMENTControl Group 1

Placebo: 2 spoons (15g), twice per day. Placebo for Calcium & Magnesium:3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day.

DIETARY_SUPPLEMENTControl Group 2 with Nutrilite Lifestyle

Placebo: 2 spoons (15g), twice per day. Placebo for Calcium & Magnesium:3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day. Practice according to Nutrilite Lifestyle Guideline per day.

Sponsors

Amway (China) R&D Center
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Chinese males or females, age between 50-70; * SPPB scale 4 - 9, but walking 400 meters within 15 minutes; * Reporting \<20 min/week in the past month performing regular physical activity and \<125 min/week of moderate physical activity; * Willing to comply with all research requirements and procedures; * Understand the test procedure, read, and sign an appropriate Informed Consent Form indicating their willingness to participate.

Exclusion criteria

* Have used any medication for OA & SA at least one month before this study. * Subject having done plastic surgery for OA & SA. * Be involved in any aspect of test administration, i.e., evaluating or overseeing activities related to product. * Have participated in any clinical study involving the test sites within the previous 6 months, or is subject participating in any clinical study concurrently. * Have a history of any type of metabolic syndrome, including but not limited to any type of diabetes, obesity and heart disease. * Have a history of any disease or the presence of health condition on the study sites that the Investigator feels would interfere with the study. * Be taking antihistamines (\> 3x/week) or anti-inflammatory (\> 8x/week) on a regular basis, or has the subject taken systemic or topical steroidal medications within 4 weeks of study enrolment. * Have any of the following conditions or factors that the investigator believes may affect the study objectives caused by medication by protein, glucosamine, calcium and magnesium or supplements to improve capability of the sports. * Have any allergy caused by all-plant protein and sea-food. * The regular exercises more than 125 minutes per week.

Design outcomes

Primary

MeasureTime frameDescription
Change of Short Physical Performance Battery (SPPB) score from baselinebaseline day 0, day 180Change of Short Physical Performance Battery (SPPB) score \[0,12\] from baseline to day 180

Secondary

MeasureTime frameDescription
Change of Visual Analogue Scale/Score (VAS) from baselinebaseline day 0, day 90, day 180Change of Visual Analogue Scale/Score (VAS), with range from 0 to 10 (the smaller the score, the better visual result), from baseline to day 90 and day 180
Change of Chalder Fatigue Scale (CFS) from baselinebaseline day 0, day 90, day 180Change of Chalder Fatigue Scale (CFS), FS-14, with range from 0 to 14 (the bigger the score, the more fatigue a person feels), from baseline to day 90 and day 180
Change of WOMAC Questionnaire Scores from baselinebaseline day 0, day 90, day 180Change of WOMAC Questionnaire Scores from baseline to day 90 and day 180
Change of Hand & Grip Strength measured by Jamar Smart Hand Dynamometer from baselinebaseline day 0, day 90, day 180Change of Hand & Grip Strength measured by Jamar Smart Hand Dynamometer from baseline to day 90 and day 180
Change of bone density measured by DXA Bone Densitometer from baselinebaseline day 0, day 90, day 180Change of bone density measured by DXA Bone Densitometer from baseline to day 90 and day 180
Improvement of Fat and Muscle Portions measured by Inbody S10 from baselinebaseline day 0, day 90, day 180Improvement of Fat and Muscle Portions measured by Inbody S10 from baseline to day 90 and day 180

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026